Nuclear Diagnostic Products Of Philadelphia, Inc.
Cherry Hill, NJ Doing business as Cherry Hill Pharmacy Part of Pharmalogic Holdings Corp.
- UEI
- QJKJD5FKTNP3
- CAGE
- 6XCB6
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Pharmalogic Holdings Corp., ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Pharmalogic Holdings Corp. · Boca Raton, FL
HVFXH4DBMXF2
-
Parent
Pharmalogic Holdings Corp. · Boca Raton, FL
HVFXH4DBMXF2
- SAM.gov registration date
- Physical address
- 2 Keystone Ave #200, Cherry Hill, NJ 08003, USA
- Website
- radiopharmacy.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $1,180,160 |
| FY2025 | $1,410,930 |
| FY2024 | $261,800 |
| FY2023 | $1,018,500 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $1,180,160 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Netspot (gallium 68) doses | Veterans Integrated Service Network 4 (VHA) | $126,204 | |
| Illuccix | Veterans Integrated Service Network 4 (VHA) | $1,167,000 | |
| GA68 radiopharmaceutical | Veterans Integrated Service Network 4 (VHA) | $66,487 | |
| Illuccix | Veterans Integrated Service Network 4 (VHA) | $1,266,500 | |
| Illuccix | Veterans Integrated Service Network 4 (VHA) | $856,400 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Nuclear Diagnostic Products Of Philadelphia, Inc., doing business as Cherry Hill Pharmacy, is a radiopharmaceutical supplier to the Department of Veterans Affairs that operates exclusively as a prime contractor under a single-award indefinite delivery contract with VA Veterans Health Administration Veterans Integrated Service Network 4. The vendor is a for-profit corporate entity and a subsidiary of Pharmalogic Holdings Corp., headquartered in Cherry Hill, New Jersey, and delivers Gallium 68 radiopharmaceutical products (ILLUCCIX and NETSPOT) for positron emission tomography imaging and nuclear medicine diagnostics supporting veteran healthcare in the northeastern United States.
Nuclear Diagnostic Products operates within NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals), with 12 federal awards carrying combined potential value of $21.1 million across the past four years. Customer concentration is absolute: 100% of awards come from VA-VHA VISN 4, with which the vendor maintains a single-award indefinite delivery contract ceiling of $4.987 million running through November 3, 2027. The vendor's primary vehicle is this IDC, under which four delivery orders have been issued carrying $12.6 million in combined potential value. A second smaller IDC (ceiling $1 million) supports two additional task orders, primarily for NETSPOT supply under small business set-aside classification. Recent award examples include a $1.167 million delivery order for ILLUCCIX issued November 4, 2025, with completion scheduled for November 3, 2026; a $1.267 million delivery order for ILLUCCIX issued November 4, 2024; and a $126,203.55 purchase order for NETSPOT doses issued June 4, 2026, under a total small business set-aside.
Award activity has contracted year over year from three awards in 2022 to one in 2026, with three awards (combined potential value $10.6 million) reaching ultimate completion inside the next twenty-four months. Only $5.2 million of the $21.1 million combined potential value has been obligated to date, reflecting the delivery-order structure of the underlying IDC. The vendor operates as a sole supplier of ILLUCCIX within VA-VHA VISN 4 and competes under both full-and-open and small business set-aside designations depending on the delivery order classification. No subcontract footprint is reported; all awards are direct prime delivery orders to VA-VHA VISN 4.
Quick answers
Is Nuclear Diagnostic Products Of Philadelphia, Inc. registered in SAM.gov?
Yes. Nuclear Diagnostic Products Of Philadelphia, Inc.'s SAM.gov registration is active through December 21, 2026.
How much has Nuclear Diagnostic Products Of Philadelphia, Inc. received in federal contracts?
Federal contracts obligated $1,410,930 to Nuclear Diagnostic Products Of Philadelphia, Inc. in fiscal year 2025 and $3,871,391 in fiscal years 2023 through 2027.
How does Nuclear Diagnostic Products Of Philadelphia, Inc. rank among federal contractors?
Nuclear Diagnostic Products Of Philadelphia, Inc.'s parent company, Pharmalogic Holdings Corp., ranked #30 in NAICS 325412, #41 in PSC 6505 and #42 in NAICS 3254 in FY2025.
What is Nuclear Diagnostic Products Of Philadelphia, Inc.'s most recent federal award?
Nuclear Diagnostic Products Of Philadelphia, Inc.'s most recent federal contract award is Netspot (gallium 68) doses (36C24426P0339), from Veterans Integrated Service Network 4 (VHA), on June 4, 2026.
On GovTribe
See Nuclear Diagnostic Products Of Philadelphia, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors